Millennium Management’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-343,595
Closed -$622K – 6796
2023
Q2
$622K Buy
343,595
+202,554
+144% +$370K ﹤0.01% 4391
2023
Q1
$186K Buy
141,041
+91,032
+182% +$149K ﹤0.01% 5202
2022
Q4
$85K Buy
50,009
+9,228
+23% +$11.7K ﹤0.01% 5633
2022
Q3
$75K Sell
40,781
-40,046
-50% -$119K ﹤0.01% 6062
2022
Q2
$248K Sell
80,827
-164,341
-67% -$1M ﹤0.01% 5516
2022
Q1
$1.77M Buy
245,168
+10,770
+5% +$106K ﹤0.01% 4003
2021
Q4
$3.84M Sell
234,398
-277,485
-54% -$3.23M ﹤0.01% 3163
2021
Q3
$5.09M Sell
511,883
-10,620
-2% -$106K ﹤0.01% 2836
2021
Q2
$5.22M Buy
522,503
+47,503
+10% +$477K ﹤0.01% 2698
2021
Q1
$4.73M Buy
+475,000
New +$4.91M ﹤0.01% 2627

Other funds holding PRDS

Millennium Management's PRDS Position: Q3 2023 in Review

Millennium Management sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 343,595 shares — an estimated $622K sold.

Millennium Management first reported a position in PRDS in Q1 2021 and held it in 10 quarters. The position peaked at $5.22M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

  • Millennium Management reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Millennium Management sold 343,595 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $622K.
  • Millennium Management first reported a position in Pardes Biosciences, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • Millennium Management's Pardes Biosciences, Inc. Common Stock position peaked at $5.22M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.